INTRODUCTION
============

Essential hypertension (EH) is caused by both genetic and environmental factors. It is generally presumed that EH is a multifactorial inheritance disorder involving several susceptibility genes. Thus, it is important to identify susceptibility genes of EH. However, although there have been studies of relationships between several candidate genes and EH, the major susceptibility genes of EH have not been identified ([@R1]).

It was previously predicted that EH is related to disorders in the coagulation-fibrinolytic balance ([@R2], [@R3]). The blood coagulation and fibrinolysis system is regulated by the interaction of many factors. Tissue plasminogen activator (t-PA), which converts plasminogen to plasmin, plays an important role in plasma circulation ([@R4]), and increased levels of t-PA antigen may predict risk of cardiovascular diseases such as myocardial infarction (MI) and thrombotic stroke ([@R5], [@R6]). It has been reported that release of t-PA appears to be associated with activity of the endogenous kininogen/kinin system, which is related to EH ([@R7]).

Thus, the available evidence suggests that the t-PA gene is associated with EH. However, the relationship between EH and the t-PA gene has not been examined using an association study. The human t-PA gene has been mapped to chromosome 8p12-p11.2. It consists of 14 exons and 13 introns, and spans approximately 32 kb ([@R8]). The present haplotype-based case-control study is the first to investigate whether single nucleotide polymorphisms (SNPs) in the human t-PA gene are associated with EH.

METHODS
=======

Subjects
--------

The EH subjects were 276 Japanese patients (mean age, 60.0 ± 5.6 years years) with EH diagnosed according to World Health Organization criteria, which included a sitting systolic blood pressure (SBP) of \>160 mmHg and/or diastolic blood pressure (DBP) of \>100 mmHg on 3 different occasions during the 2 months following the first medical examination. None of the EH subjects was using antihypertensive medication. Patients diagnosed with secondary hypertension were excluded. The controls were 283 Japanese normotensive (NT) healthy individuals (mean age, 77.9 ± 4.6 years). None of the control subjects had a family history of hypertension, and all had a SBP of \<130 mmHg and a DBP of \<85 mmHg. A family history of hypertension was defined as prior diagnosis of hypertension in a grandparent, uncle, aunt, parent or sibling. Both groups were recruited from the northern area of Tokyo, Japan. Informed consent was obtained from each subject according to a protocol approved by the Human Studies Committee of Nihon University ([@R9]).

Biochemical analysis
--------------------

Plasma concentrations of total cholesterol and high-density lipoprotein (HDL)-cholesterol and serum concentrations of creatinine and uric acid were measured using the methods of the Clinical Laboratory Department of Nihon University Hospital ([@R10]).

Genotyping
----------

Based on information from the National Center for Biotechnology Information (NCBI) SNP database or the Applied Biosystems (Foster City, CA) - Celera Discovery System (CDS) database (<http://www.appliedbiosystems.com>), we chose SNPs that had a minor allele frequency of \>20%. For the genetic association analysis, we selected the following 3 SNPs in the human t-PA gene: rs7007329 (G/C), located at nucleotide (nt) -4360 upstream of the transcription initiation site; rs8178750 (T/C), nt +20324 in intron 6; rs4471024 (G/A), nt +624 downstream of the terminal codon (Figure [1](#F1){ref-type="fig"}). Genotypes were determined using Assays-on-Demand kits (Applied Biosystems) and TaqMan PCR, as described previously ([@R11]).
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Haplotype-based case-control analysis
-------------------------------------

We performed haplotype-based case-control analysis of 4 combinations of the 3 SNPs. The frequency of each haplotype was estimated using the expectation/maximization (EM) algorithm ([@R12], [@R13]). Haplotype and linkage disequilibrium (LD) analyses were performed using the software SNPAlyze version 3.2 (DYNACOM Co., Ltd. Yokohama, Japan), which is available from the website <http://www.dynacom.co.jp/products/package/snpalyze/index.html>.

Statistical analysis
--------------------

Data are shown as mean ± SD. Differences in clinical data between the EH and NT groups were assessed using analysis of variance (ANOVA) followed by a Fisher's protected least significant difference (PLSD) test. Hardy-Weinberg equilibrium was assessed using chi-square analysis. If expected values were small (\<2.0), the genotypes with the small expected values were combined ([@R14]). The overall distribution of SNP alleles was analyzed using 2 × 2 contingency tables, and differences in distribution of the SNP genotypes between the EH patients and NT controls were assessed using a 2-sided Fisher exact test and multiple logistic regression analysis. Statistical significance was established at *p*\<0.05. The threshold value of the frequencies of the haplotypes included in the analysis was set to 1%. All haplotypes below the threshold value were excluded from the analysis. Overall distribution of haplotypes was analyzed using 2 × m contingency tables, with a *p* value of \<0.05 considered to indicate statistical significance. The *p* value of each haplotype was determined using chi-square analysis, the permutation method, and SNPAlyze version 3.2 ([@R14]). Pair-wise linkage disequilibrium (LD) patterns for the t-PA gene were evaluated using \|D'\| and r2.

RESULTS
=======

Table [1](#T1){ref-type="table"} shows clinical characteristics of the subjects. There were significant differences in body mass index (BMI), SBP and DBP between EH and NT subjects. Among male subjects, there were significant differences in pulse rate, total cholesterol, smoking habit, uric acid and alcohol consumption between EH and NT subjects. There were no significant differences in creatinine or HDL-cholesterol between EH and NT subjects.

###### 

Characteristics of study participants

                              Total          *p* value      Men       *p* value      Women          *p* value                                 
  --------------------------- -------------- -------------- --------- -------------- -------------- ----------- -------------- -------------- ---------
                                                                                                                                              
  Number of subjects          276            283                      180            189                        96             94             
  Age (years)                 51.0 ± 5.6     51.4 ± 8.6     0.517     50.9 ± 5.8     51.9 ± 6.7     0.138       51.2 ± 5.2     50.4 ± 11.5    0.568
  BMI (kg/m^2^)               24.6 ± 3.8     22.7 ± 3.3     \<0.001   24.7 ± 3.7     22.9 ± 3.2     \<0.001     24.3 ± 4.1     22.4 ± 3.4     0.001
  SBP (mmHg)                  173.9 ± 20.4   112.8 ± 10.6   \<0.001   171.8 ± 19.6   113.1 ± 10.3   \<0.001     177.8 ± 21.5   112.1 ± 11.4   \<0.001
  DBP (mmHg)                  105.4 ± 13.5   69.6 ± 8.3     \<0.001   105.6 ± 13.5   70.3 ± 7.9     \<0.001     105.1 ± 13.5   68.2 ± 9.0     \<0.001
  Pulse (beats/min)           77.7 ± 15.5    73.8 ± 14.1    0.006     77.6 ± 16.3    73.3 ± 15.4    0.022       77.9 ± 14.0    74.8 ± 10.9    0.142
  Creatinine (mg/dl)          0.85 ± 0.25    0.83 ± 0.22    0.422     0.94 ± 0.24    0.90 ± 0.20    0.097       0.68 ± 0.18    0.70 ± 0.18    0.394
  Total cholesterol (mg/dl)   210.5 ± 36.5   200.7 ± 41.6   0.005     204.9 ± 34.5   196.4 ± 38.6   0.033       220.3 ± 38.1   209.3 ± 46.1   0.078
  HDL cholesterol (mg/dl)     57.0 ± 17.7    56.5 ± 17.4    0.753     53.5 ± 16.8    54.3 ± 16.0    0.686       63.0 ± 17.5    61.0 ± 19.3    0.491
  Uric acid (mg/dl)           5.7 ± 1.6      5.4 ± 1.5      0.104     6.2 ± 1.5      5.8 ± 1.4      0.032       4.7 ± 1.5      4.6 ± 1.2      0.677
  Alcohol consumption (%)     67.7           60.1           0.098     83.7           72.2           0.017       37.5           35.5           0.801
  Smoking (%)                 54.2           42.0           0.011     64.7           52.8           0.038       33.7           20.6           0.078

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; EH, essential hypertension; NT, normotension.

Table [2](#T2){ref-type="table"} shows the distributions of genotype and allelic frequencies for the 3 SNPs in EH patients and NT subjects. There were no significant differences in genotype or allelic distributions of any of the SNPs between the two groups, for total subjects, male subjects or female subjects.

###### 

Genotype and allele distributions in EH patients and NT subjects

                               Total         *p* value     Men           *p* value     Female        *p* value                                               
  ---------------------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------
  **Number of participants**   276           283                         180           189                         96            94                          
  **Variants**                 EH            NT                          EH            NT                          EH            NT                          
  rs7007329                    Genotype                                                                                                                      
                               G/G           20 (0.072)    18 (0.064)                  12 (0.067)    11 (0.058)                  8 (0.083)     7 (0.074)     
                               G/C           109 (0.395)   115 (0.406)                 71 (0.394)    73 (0.386)                  38 (0.396)    42 (0.447)    
                               C/C           147 (0.533)   150 (0.530)   0.901         97 (0.539)    105 (0.556)   0.919         50 (0.521)    45 (0.479)    0.775
                               Allele                                                                                                                        
                               G             149 (0.270)   151 (0.267)                 95 (0.264)    95 (0.251)                  54 (0.281)    56 (0.298)    
                               C             403 (0.730)   415 (0.733)   0.906         265 (0.736)   283 (0.749)   0.696         138 (0.719)   132 (0.702)   0.721
  rs8178750                    Genotype                                                                                                                      
                               T/T           3 (0.011)     1 (0.004)                   1 (0.006)     0 (0)                       2 (0.021)     1 (0.011)     
  T/C                          11 (0.040)    10 (0.035)                  6 (0.033)     7 (0.037)                   5 (0.052)     3 (0.032)                   
  C/C                          262 (0.949)   272 (0.961)   0.563         173 (0.961)   182 (0.963)   0.581         89 (0.927)    90 (0.957)    0.614         
  Allele                                                                                                                                                     
  T                            17 (0.031)    12 (0.021)                  8 (0.022)     7 (0.019)                   9 (0.047)     5 (0.027)                   
  C                            535 (0.969)   554 (0.979)   0.313         352 (0.978)   371 (0.981)   0.722         183 (0.953)   183 (0.973)   0.294         
  rs4471024                    Genotype                                                                                                                      
                               G/G           49 (0.177)    57 (0.201)                  29 (0.161)    39 (0.207)                  20 (0.208)    18 (0.192)    
  G/A                          133 (0.482)   130 (0.459)                 88 (0.489)    87 (0.460)                  45 (0.469)    43 (0.457)                  
  A/A                          94 (0.341)    96 (0.339)    0.752         63 (0.350)    63 (0.333)    0.533         31 (0.323)    33 (0.351)    0.908         
  Allele                                                                                                                                                     
  G                            231 (0.418)   244 (0.431)                 146 (0.406)   165 (0.437)                 85 (0.443)    79 (0.420)                  
  A                            321 (0.582)   322 (0.569)   0.670         214 (0.594)   213 (0.563)   0.395         107 (0.557)   109 (0.580)   0.658         

EH, essential hypertension; NT, normotension.

There were no significant differences in haplotype distributions between EH patients and NT subjects (Table [3](#T3){ref-type="table"}).

###### 

Haplotype distribution analysis using combinations of the 3 SNPs

  Combination of SNPs             Overall *P*-value Haplotype   EH      NT      Individual chi-square   Individual *P*-value Individual
  ------------------------------- ----------------------------- ------- ------- ----------------------- ---------------------------------
                                                                                                        
  rs7007329/rs8178750/rs4471024   0.457CCA                      0.534   0.508   0.646                   0.422
                                  GCA                           0.027   0.043   1.861                   0.173
  CTA                             0.020                         0.018   0.087   0.768                   
  CCG                             0.179                         0.208   1.389   0.239                   
  GCG                             0.241                         0.223   0.426   0.514                   
  rs7007329/rs8178750             0.954CC                       0.712   0.716   0.020                   0.887
                                  GC                            0.267   0.266   0.003                   0.957
  CT                              0.020                         0.018   0.087   0.768                   
  rs7007329/rs4471024             0.344CA                       0.553   0.526   0.762                   0.383
                                  GA                            0.029   0.043   1.458                   0.227
  CG                              0.177                         0.207   1.532   0.216                   
  GG                              0.241                         0.224   0.429   0.512                   
  rs8178750/rs4471024             0.735CA                       0.558   0.551   0.055                   0.815
                                  TA                            0.024   0.018   0.493                   0.483
  CG                              0.418                         0.431   0.191   0.662                   

EH, essential hypertension; NT, normotension.

Table [4](#T4){ref-type="table"} shows pair-wise linkage disequilibrium (LD) patterns for the t-PA gene. All SNPs were located in 1 haplotype block.

###### 

Pairwise linkage disequilibrium(LD) of t-PA gene

  SNPs           rs7007329   rs8178750      rs4471024
  -------------- ----------- -------------- -----------
                                            
  rs7007329      \|D´\|      0.3452         0.7188
                 r^2^        0.0009         0.2481
                 rs8178750   \|D´\|         0.7197
                             r^2^           0.0085
                             rs4471024      \|D´\|
                                            r^2^
  \|D´\|\> 0.5               \|D´\|\> 0.3   
  r^2^ \>0.25                               

DISCUSSIONS
===========

In the present study, using haplotype-based case-control analysis and 3 SNPs, we did not find an association between EH and the human t-PA gene.

There have been several previous studies of relationships between the fibrinolytic system and EH. The fibrinolytic system consists of many factors, including t-PA and plasminogen activator inhibitor 1 (PAI-1). A study by Keskin *et al*. suggests that indicators of fibrinolytic activity such as plasma levels of PAI-1 and beta thromboglobulin (BTG) are associated with EH, but they did not find a relationship between EH and plasma levels of t-PA ([@R15]). In addition, the function of t-PA is modulated by interaction with other factors such as PAI-1. Jastrzebska *et al*. studied relationships between t-PA levels and PAI-1 gene polymorphisms in EH and NT subjects. Their comparison of the 4G allele of an insertion/deletion polymorphism in PAI-1 gene carriers (4G/4G homozygotes) revealed that EH patients had significantly higher levels of fibrinogen (*p*=0.045), PAI-1 (*p*=0.009), and t-PA (*p*=0.007) than NT controls ([@R16]). Their data indicate that the t-PA gene is associated with atherothrombotic disease, but not EH.

In a previous association study using an Alu-repeat polymorphism in the t-PA gene, there were no significant differences between EH and NT subjects ([@R17]). The present strategy of haplotype-based case-control analysis is a more effective method of identifying susceptibility genes than case-control analysis using 1 plolymorphism ([@R18], [@R19]). Our previous LD analysis showed that the \|D'\| and r2 values of the 3 present SNPs were suitable for haplotype-based case-control analysis ([@R20], [@R21]). Moreover, those 3 SNPs are very useful as genetic markers because they have high minor allele frequencies (\>20%).

In conclusion, the present results do not indicate an association between the t-PA gene and EH.
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